|
关注：1
2013-05-23 12:21
求翻译：Subjects who elect to continue and were rerandomized to placebo at Week 52 will have ustekinumab injections reinstituted at their next scheduled visit. Subjects who elect to continue and were rerandomized to ustekinumab at Week 52 will continue with ustekinumab dose at their scheduled visits.是什么意思？ 待解决
 悬赏分：1
- 离问题结束还有
Subjects who elect to continue and were rerandomized to placebo at Week 52 will have ustekinumab injections reinstituted at their next scheduled visit. Subjects who elect to continue and were rerandomized to ustekinumab at Week 52 will continue with ustekinumab dose at their scheduled visits.
问题补充： |
|
2013-05-23 12:21:38
正在翻译，请等待...
|
|
2013-05-23 12:23:18
主体选择继续执行,与安慰剂rerandomized52将在一周内注射剂再提起ustekinumab也在预定举行的下次访问。 主体选择继续,rerandomized ustekinumab,在一周内将继续52ustekinumab剂量与在外访。
|
|
2013-05-23 12:24:58
决定继续的主题和是rerandomized对安慰剂在星期52把ustekinumab射入被再创立在他们的其次预定的参观。 决定继续的主题和是rerandomized对ustekinumab在星期52将继续通过ustekinumab药量在他们的预定的参观。
|
|
2013-05-23 12:26:38
选举继续被 rerandomized 52 周的安慰剂的受试者会提起在他们下次预定访问 ustekinumab 注射。籍人士选举继续被 rerandomized 到 ustekinumab 在 52 周将继续与 ustekinumab 剂量在他们预定的访问。
|
|
2013-05-23 12:28:18
使谁遭受继续的当选者和被在第 52 星期到为死者所诵的晚祷词重新使随机化将喝在他们的下一个预定访问被重新建立的 ustekinumab 注射剂。选择继续，在第 52 星期到 ustekinumab 被重新使其随机化的臣民在他们的预定访问将继续 ustekinumab 药。
|
湖北省互联网违法和不良信息举报平台 | 网上有害信息举报专区 | 电信诈骗举报专区 | 涉历史虚无主义有害信息举报专区 | 涉企侵权举报专区
